Interphex Insider: The Future-Ready Biomanufacturing Facility
Meg Carr reflects on the key themes from this year’s show – from contamination control and AI to flexible facility design
Clinical Scorecard: Interphex Insider: The Future-Ready Biomanufacturing Facility
At a Glance
Category Detail
Condition Biomanufacturing Operations Key Mechanisms Proactive contamination control, AI and automation integration, flexible facility design Target Population Biopharma manufacturers and operators Care Setting Biomanufacturing facilities
Key Highlights
Shift from theoretical concepts to practical execution in biomanufacturing Emphasis on proactive contamination control and cleaning innovation Integration of AI and automation for improved reliability and quality oversight Focus on sustainability and next-generation bioprocessing Evolving facility strategies towards flexibility and modularity Guideline-Based Recommendations
Diagnosis
Assess contamination risks across facility design and operations Management
Implement holistic contamination control strategies early in facility design Monitoring & Follow-up
Utilize AI and automation for real-time monitoring and risk identification Risks
Address the gap between process complexity and contamination management Patient & Prescribing Data
Not applicable; focused on biomanufacturing facilities
N/A
Clinical Best Practices
Design facilities for flexibility and risk-based control from inception Embed contamination considerations in early design phases Adopt modular strategies and right-sized cleanroom approaches Ensure digital readiness for data integrity and decision-making Related Resources & Content
